Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

Young African Businesswoman Analyzing Data On Multiple Computer Screen In Office

ANZ Group Holdings Ltd (ASX: ANZ)

According to a note out of Goldman Sachs, its analysts have upgraded this banking giant's shares to a buy rating with a $27.38 price target. The broker has also added ANZ to its coveted conviction list and crowned it as the best big four bank to buy now. This is based on its confidence in the sustainability of ANZ's improvement in its Institutional returns. The ANZ share price is trading at $23.61 on Friday afternoon.

Paladin Energy Ltd (ASX: PDN)

A note out of Macquarie reveals that its analysts have retained their outperform rating and $1.10 price target on this uranium developer's shares. This follows an update on its progress in restarting the Langer Heinrich uranium mine. Macquarie was pleased that the company remains on course to restart production in the first quarter of 2024. This bodes well for Paladin given the increasing demand for uranium and tight market conditions. The Paladin Energy share price is fetching 74 cents today.

Telix Pharmaceuticals Ltd (ASX: TLX)

Analysts at Bell Potter have retained their buy rating and $14 price target on this radiopharmaceutical company's shares. Bell Potter was pleased with the company's recent acquisition of the Dedicaid AI platform for nuclear medicine. It feels this could put the company at the forefront of plugging a gap in the US market. The Telix share price is trading at $11.29 today.

Motley Fool contributor James Mickleboro has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A little girl has a huge smile and a giant lollipop.
Broker Notes

6 ASX shares tipped by brokers to rise 34% to 87%

Post-earnings season, brokers have updated their 12-month price targets on scores of stocks.

Read more »

Happy businessman fist pumping while looking at a tablet.
Broker Notes

2 ASX shares tipped to return 19% to 47%

Recent sell-offs have caught Morgans’ attention, with the broker now rating both shares as buys.

Read more »

Man sitting in a plane looking through a window and working on a laptop.
Broker Notes

Buy, hold, sell: Dicker Data, Polynovo, Flight Centre shares

Here's what the experts think.

Read more »

Two scientists analysing results on a computer screen.
Healthcare Shares

3 ASX healthcare shares to buy with 25% to 100% upside as sector rebound races higher

After slumping to a 9-year low on 3 June, healthcare shares have rallied by an extraordinary 42%.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Broker Notes

How high could Bubs Australia shares go, according to Bell Potter?

A key approval is expected to boost the Bubs share price.

Read more »

a woman in a business suit looks wide eyed and interested as she holds a tin can with string to hear ear listening to some news.
Broker Notes

UBS names its 10 top ASX picks for the next 3-6 months

Here are the 10 ASX shares UBS thinks could outperform.

Read more »

Happy teen friends jumping in front of a wall.
Broker Notes

Guess which ASX stock could rise 85%

Bell Potter sees significant upside from this stock.

Read more »

Buy the dip written on a yellow sign.
Broker Notes

Down 43%! 4 reasons to buy the BIG dip in Pro Medicus shares today

A leading expert believes Pro Medicus shares are well-place to rebound.

Read more »